Interleukin-2 in metastatic melanoma: what is the current role?
Atkins
M B
MB
D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D008545:Melanoma / Q000556:secondary / Q000628:therapy*
D007376:Interleukin-2